Meeting
Abstract Number: 105
SHM Converge 2023
Background: Stroke is the leading cause of mortality worldwide. However, available treatment options are limited due to the narrow treatment time window and reperfusion injury after revascularization. New treatment modalities to overcome these challenges are in need. Chlorpromazine and promethazine (C+P) have been utilized for cerebral edema, central high fever with restlessness, and delirium [1, […]
Abstract Number: 165
SHM Converge 2023
Background: Approximately one-third of patients with acute ischemic stroke (AIS) develop hyperglycemia regardless of pre-existing history of diabetes [1]. Hyperglycemia is associated with increased risk of hemorrhagic transformation and can be considered as a predictor of poor functional outcome after intravenous thrombolysis (IVT) and mechanical thrombectomy (MT) [2]. Additionally, risk of death, hemorrhagic complications, and […]
Abstract Number: 183
SHM Converge 2023
Background: Patent Foramen Ovale (PFO) is a common abnormality that affects between 25% and 34% of the general population. For most people, it is a benign finding; however, in some, the PFO can be wider, allowing a paradoxical embolus to transit from the venous to the arterial circulation, which is associated with cryptogenic stroke, migraine, […]